HerbParlor
Ginger (Zingiber officinale Roscoe)Emerging evidence

Ginger

Zingiber officinale Roscoe

Overview

At a glance

Ginger is the rhizome of Zingiber officinale Roscoe, a Zingiberaceae botanical used widely as a culinary spice and in traditional and contemporary herbal preparations. Human research is substantial but outcome- and preparation-dependent.

Key takeaway

Ginger is not one uniform intervention. Species identity, plant part (rhizome), preparation (fresh, dried, powder, tea, extract, capsule, tablet, essential oil) and whether the product is whole rhizome material or a standardized or specialized extract all matter when interpreting research. Evidence should be discussed separately for pregnancy-related nausea/vomiting, menstrual pain, motion sickness, osteoarthritis/pain and gastrointestinal outcomes rather than collapsed into a general “ginger is effective” statement.

Common uses studied

Culinary spice and food useTraditional herbal usePregnancy-related nausea/vomiting researchMenstrual-pain researchMotion-sickness researchOsteoarthritis and pain researchGastrointestinal-symptom researchCommercial Ginger preparations

Start here

What are you trying to figure out?

Pick the question closest to yours. Each card jumps to the relevant part of this profile or an existing HerbParlor tool — no sponsored rankings, no hidden ordering.

Understand the herbExplore the evidenceUnderstand formsCheck safetyEvaluate a supplementCompare options

Identity

What is this herb?

Family

Zingiberaceae

Species

Zingiber officinale Roscoe

Common names

GingerGinger rootCommon gingerTrue gingerAdrak

Plant parts used

Rhizome

Geographic context

Kew records Zingiber officinale Roscoe as the accepted species; its rhizome is the principal herbal material. Geographic origin is reported only where supported by the Kew record.

Identification notes

This profile refers to the accepted species Zingiber officinale Roscoe. Ginger root, ginger extract, ginger tea, ginger powder and ginger oil are preparations or forms of the same canonical herb, not separate entities. Ginger essential oil is a distinct preparation and is not interchangeable with oral rhizome products. Other Zingiber species should not be treated as equivalent to Zingiber officinale Roscoe.

Background

Traditional context

Traditions

Asian, Middle Eastern and European culinary and herbal-medicine contexts

Historical uses

Traditional use of Zingiber officinale rhizome preparationsHistorical use related to digestion, nausea and general discomfort

Traditional and culinary use provides historical and cultural context and should not be treated as proof of clinical efficacy. Clinical conclusions should be based on the specific human evidence and preparation studied.

Preparations

Forms & preparations

Forms

Fresh rhizomeDried rhizomeGinger powderTea / infusionCapsuleTabletLiquid extract / tinctureStandardized extractSpecialized preparation (such as steamed extract)Essential oil (distinct preparation)

Preparation methods

Fresh or dried rhizome materialPowdered rhizomeHot-water infusion (tea)Ethanolic or other liquid extractionDry extract preparationStandardized or specialized extraction where explicitly disclosedSteam distillation for essential oil

What changes between forms

  • Fresh rhizome, dried rhizome, ginger powder, tea, liquid extract and dry extract are not automatically equivalent preparations.
  • A standardized or specialized extract (such as a steamed ginger extract) is a specific preparation and is not interchangeable with ordinary ginger powder, tea or every commercial product.
  • Ginger essential oil is a distinct preparation and is not interchangeable with oral rhizome products; oral ingestion of essential oils should not be assumed to be equivalent to rhizome preparations.
  • Different ginger preparations may differ in dose, chemical composition, extraction method and clinical evidence.
  • Combination formulas should not automatically be treated as evidence for Ginger alone.

Human studies have used different Zingiber officinale preparations, including powders, extracts and specialized preparations such as steamed extracts. Findings from a specific preparation should not automatically be generalized to every Ginger product.

Research

Research Explorer

Each question summarizes what human research has examined, how it was studied, and the main limitations — not a treatment recommendation.

What does human evidence show about Ginger and pregnancy-related nausea/vomiting?

Population

Pregnant individuals studied for nausea- and vomiting-related outcomes in clinical trials, systematic reviews and umbrella reviews of Zingiber officinale preparations.

Intervention

Zingiber officinale rhizome preparations, including powders and extracts where specified.

Comparator

Placebo, no treatment or comparator interventions where used.

Outcomes studied

NauseaVomitingNausea-and-vomiting composite measuresAdverse events

Evidence assessment

There are signals of benefit for pregnancy-related nausea, but the evidence is heterogeneous and the underlying reviews have been judged to be of generally low quality. Nausea and vomiting should be distinguished as outcomes rather than treated as a single measure. Recent umbrella reviews found methodological limitations and heterogeneity that limit confidence. Findings do not establish Ginger as a proven treatment for pregnancy-related nausea or vomiting, and no pregnancy dosage recommendation is provided.

Limitations

  • Heterogeneity across included studies and reviews
  • Generally low methodological quality of included reviews
  • Different preparations, doses, durations and outcome measures
  • Findings should not be generalized to every commercial Ginger product
  • No pregnancy dosage recommendation is made

Sources

What does human evidence show about Ginger and menstrual pain?

Population

Individuals with primary dysmenorrhea studied in clinical trials and a systematic review/meta-analysis of Zingiber officinale preparations.

Intervention

Zingiber officinale rhizome preparations as described in the included studies.

Comparator

Placebo, no treatment or comparator interventions where used.

Outcomes studied

Pain intensityPain reliefAdverse events

Evidence assessment

A 2024 systematic review and meta-analysis reported findings suggestive of reduced menstrual pain. The interpretation is limited by risk-of-bias concerns and an uncertain risk-benefit balance. These findings do not amount to a treatment recommendation and should not be generalized to unrelated pain conditions.

Limitations

  • Risk-of-bias concerns in the included studies
  • Uncertain risk-benefit balance
  • Different preparations, doses and outcome measures
  • Not a treatment recommendation

Sources

What does human evidence show about motion sickness?

Population

Individuals studied for motion-sickness outcomes in clinical trials of Zingiber officinale preparations.

Intervention

Zingiber officinale rhizome preparations as described in the relevant studies.

Comparator

Placebo or comparator interventions where used.

Outcomes studied

Motion-sickness symptomsNauseaVomiting

Evidence assessment

According to NCCIH, most studies have not shown a benefit of ginger for motion sickness. The evidence does not establish Ginger as an effective motion-sickness treatment.

Limitations

  • Most studies have not shown benefit
  • Variation in preparations and outcome measures
  • Findings should not be generalized to every commercial product

Sources

What does human evidence show about osteoarthritis and pain?

Population

Individuals with osteoarthritis or pain-related conditions studied in clinical research on Zingiber officinale preparations.

Intervention

Oral and, where specified, topical Zingiber officinale preparations.

Comparator

Placebo or comparator interventions where used.

Outcomes studied

PainFunctionStiffnessAdverse events

Evidence assessment

Evidence for osteoarthritis and pain is limited and uncertain, with methodological-quality concerns. Oral and topical ginger evidence should be distinguished. Findings do not establish Ginger as a proven treatment for osteoarthritis or pain.

Limitations

  • Limited and uncertain evidence
  • Methodological-quality concerns
  • Oral and topical preparations should be distinguished
  • Findings should not be generalized to every pain condition

Sources

What does human evidence show about gastrointestinal symptoms?

Population

Individuals studied for gastrointestinal-symptom outcomes in clinical research on Zingiber officinale preparations.

Intervention

Zingiber officinale preparations, including a specific steamed ginger extract where studied.

Comparator

Placebo or comparator interventions where used.

Outcomes studied

Gastrointestinal symptomsFunctional dyspepsia measuresAdverse events

Evidence assessment

A 2025 randomized controlled trial examined a specific steamed ginger extract for functional dyspepsia. This is preparation-specific evidence and must not be generalized to ordinary ginger powder, tea or every ginger supplement. Broader gastrointestinal evidence remains limited and preparation-dependent.

Limitations

  • Preparation-specific evidence (steamed extract) does not apply to every Ginger product
  • Limited and preparation-dependent broader gastrointestinal evidence
  • Different preparations and outcome measures

Sources

How much do outcomes depend on the preparation studied?

Population

People comparing commercial Ginger products with the preparations studied in human research.

Intervention

Different Zingiber officinale preparations (fresh, dried, powder, tea, extracts, standardized or specialized extracts, essential oil).

Comparator

Not applicable.

Outcomes studied

Preparation identityEvidence interpretability

Evidence assessment

Clinical findings are preparation-dependent. A fresh rhizome, a dried powder, a tea, a standardized extract and a specialized preparation such as a steamed extract may differ in composition and should not be treated as interchangeable interventions. Essential oil is a distinct preparation and is not interchangeable with oral rhizome products.

Limitations

  • Commercial labels may omit preparation details
  • Studies do not use one uniform Zingiber officinale intervention
  • Standardization is not consistently disclosed or comparable

Sources

How strong and consistent is the overall human evidence?

Population

Individuals represented across the available Zingiber officinale human clinical literature.

Intervention

Zingiber officinale rhizome preparations studied in human research.

Comparator

Varies by study and review.

Outcomes studied

Pregnancy-related nausea/vomitingMenstrual painMotion sicknessOsteoarthritis/painGastrointestinal symptomsAdverse events

Evidence assessment

The overall human evidence is substantial in volume but inconsistent in quality and outcome. Pregnancy-related nausea shows signals but with heterogeneity and generally low-quality underlying reviews; menstrual-pain evidence is suggestive but risk-of-bias-limited; motion-sickness evidence has not shown benefit in most studies; osteoarthritis/pain evidence is limited and uncertain; and gastrointestinal evidence is preparation-specific. The evidence does not support a universal “ginger is effective” claim across all uses.

Limitations

  • Outcome- and preparation-dependent findings
  • Heterogeneity and methodological-quality concerns across reviews
  • Risk of overinterpreting signals as established efficacy
  • Limited ability to infer effects for commercial products

Sources

Latest evidence

Recently published research

Searching Europe PMC…

Looking for recent publications…

These publications are automatically discovered from Europe PMC. They have not necessarily been independently reviewed by HerbParlor and are not automatically incorporated into the evidence assessment.

Evidence

Evidence

Human research on Zingiber officinale is substantial but outcome- and preparation-dependent. There are signals of benefit for pregnancy-related nausea and for menstrual pain, but both are limited by heterogeneity, risk-of-bias and methodological-quality concerns; motion-sickness studies have generally not shown benefit; osteoarthritis/pain evidence is limited and uncertain; and gastrointestinal evidence is preparation-specific. Current evidence does not establish Ginger as a proven treatment for pregnancy-related nausea or vomiting, dysmenorrhea, motion sickness, osteoarthritis, functional dyspepsia or any other disease.

Evidence tier

Emerging

Confidence

Overall confidence is emerging rather than established. The main uncertainties concern preparation, dose, duration, study quality, sample size, outcome selection and risk of bias. Evidence from a specific preparation should not automatically be generalized to every Ginger product, and food-level ginger should not be treated as equivalent to concentrated extracts.

Last evidence review

2026-09-20

Where the evidence is strongest

Outcome-specific synthesis that separates pregnancy nausea, menstrual pain, motion sickness, osteoarthritis/pain and gastrointestinal evidencePreparation-aware interpretation distinguishing whole rhizome, powder, extracts and specialized preparations

How to interpret this

Ginger evidence should be interpreted at the level of the identified species, plant part (rhizome), preparation, amount and outcome studied. The current human literature is substantial but heterogeneous and outcome-dependent; it does not justify broad therapeutic claims, dosage recommendations, or automatic equivalence between preparations.

Automatic evidence update

Since the last editorial review

Checking Europe PMC…
Checking evidence

Checking for publications published since the last editorial evidence review…

This automatic update detects newly published literature; it does not replace HerbParlor's editorial evidence assessment. Review status is an automatic triage signal. Curated HerbParlor evidence is unchanged until editorial review.

Boundaries

What the evidence does NOT establish

Areas with limited evidence

  • A universal “ginger is effective” claim across all uses
  • Generalization across powders, teas, extracts and essential oils
  • Pregnancy dosage recommendations
  • Translation of laboratory or mechanistic findings to patient-important outcomes

Evidence gaps

  • Larger, longer and well-described randomized trials with low risk of bias
  • Direct comparisons of fresh, dried, powder, extract and specialized preparations
  • Consistent reporting of preparation, amount and extract characteristics
  • Independent confirmation of clinically meaningful outcomes across conditions

Common misconceptions

  • Ginger powder is not automatically equivalent to a standardized extract.
  • A study of one ginger extract does not validate every ginger supplement.
  • Culinary ginger and concentrated supplements are not automatically interchangeable.
  • Traditional use is not clinical proof.
  • More ginger does not automatically mean better evidence.
  • Evidence for pregnancy nausea should not be generalized to every nausea condition.
  • Evidence for menstrual pain does not establish effectiveness for unrelated pain conditions.
  • A ginger-containing combination product does not provide the same evidence as Ginger alone.

Safety

Safety & interactions

General considerations

  • Oral ginger can cause abdominal discomfort, heartburn, diarrhea, and mouth or throat irritation.
  • Safety should be interpreted according to the specific preparation, amount and duration studied. Culinary use and concentrated supplements or extracts should be distinguished; food-level ginger should not be assumed to be equivalent to concentrated extracts.
  • Pregnancy evidence is outcome- and preparation-specific; avoid blanket safety claims for pregnancy, and do not provide a pregnancy dosage recommendation.
  • Oral rhizome preparations should be distinguished from essential oils and topical products; essential oils are not interchangeable with oral rhizome products.
  • Medication and herb interaction uncertainty should be acknowledged; the available sources do not establish an exhaustive interaction list.

Pregnancy & nursing

  • Pregnancy and breastfeeding safety is outcome- and preparation-specific and should not be assumed for every Ginger preparation, particularly concentrated extracts.
  • People who are pregnant or breastfeeding should discuss a specific product with a qualified healthcare professional.

Medication interactions to be aware of

The available sources do not establish a complete interaction profile for every Zingiber officinale preparation. People taking medicines should discuss a specific product with a qualified healthcare professional rather than infer safety from culinary or traditional use.

Condition considerations

  • People with gastrointestinal, bleeding or other medical conditions should not use this profile as a substitute for clinical care.
  • Uncertainty is greater when a product does not identify its plant part, preparation or amount.

Reported adverse effects

  • Abdominal discomfort
  • Heartburn
  • Diarrhea
  • Mouth or throat irritation

Duration

  • Long-term safety of concentrated Zingiber officinale extracts is not equally established for every commercial product.

Talk to a healthcare professional if any apply

  • Pregnancy or breastfeeding
  • Use of prescription medicines
  • Gastrointestinal, bleeding or other relevant medical conditions
  • Use of a concentrated or specialized extract with unclear composition
  • Use of essential oil or topical products
  • Significant or unexpected adverse effects

Products

What changes between products?

Form differences

  • Fresh rhizome, dried rhizome, ginger powder, tea, liquid extract and dry extract are not automatically equivalent preparations.
  • A standardized or specialized extract (such as a steamed ginger extract) is a specific preparation and is not interchangeable with ordinary ginger powder, tea or every commercial product.
  • Ginger essential oil is a distinct preparation and is not interchangeable with oral rhizome products; oral ingestion of essential oils should not be assumed to be equivalent to rhizome preparations.
  • Different ginger preparations may differ in dose, chemical composition, extraction method and clinical evidence.
  • Combination formulas should not automatically be treated as evidence for Ginger alone.

Form considerations

  • Fresh rhizome, dried rhizome, powder, tea, liquid extract and dry extract can represent different amounts and preparations.
  • Essential oil is a distinct preparation and is not interchangeable with oral rhizome products.
  • Do not compare products solely by package size or headline ginger weight.

Plant part considerations

  • Confirm that the product uses identified Zingiber officinale rhizome material when that is the intended preparation.
  • Do not treat other plant parts or other Zingiber species as automatically equivalent.

Extract considerations

  • Record extract characteristics only when the product source explicitly provides them.
  • Do not infer an extraction ratio, concentration or clinical equivalence from a label that does not provide it.

Standardization considerations

  • Record declared standardization only when genuinely disclosed.
  • Do not invent gingerol percentages, extract ratios or a preferred marker threshold.
  • Do not imply that a standardized product is automatically more effective.

Evaluation

How to evaluate a supplement

What to check

  • Zingiber officinale species identity
  • Plant part, especially rhizome versus other material
  • Fresh versus dried material where disclosed
  • Whole material versus extract
  • Powder, tea, extract, capsule, tablet or other preparation
  • Amount per serving and serving information
  • Extract characteristics where explicitly disclosed
  • Standardization where explicitly disclosed
  • Marker compounds only where genuinely specified
  • Whether the product is Ginger alone or a combination formula
  • Other ingredients and label transparency
  • Identity, contaminant and batch testing where disclosed

Serving considerations

  • Compare the labelled amount and preparation with the intervention used in the relevant research without inventing a dosage recommendation.
  • A larger declared amount does not automatically mean a stronger or better-supported product.

Testing considerations

  • Look for species and plant-part identity testing where disclosed.
  • Look for contaminant testing and batch or lot traceability where disclosed.
  • Treat testing information as a product-quality disclosure, not as proof of clinical efficacy.

Label transparency

  • The species and plant part should be clear where possible.
  • Fresh, dried, powder, extract and other preparation details should be explicit.
  • The amount per serving should be explicit.
  • Combination ingredients should be listed.
  • Extract or standardization claims should be specific and sourceable.
  • Marketing language should not be treated as human clinical evidence.

Supplements

Related supplements

Sources

Authoritative sources referenced

research-reviewedLast reviewed 2026-09-20Next review 2027-09-20

Sections reviewed

overviewbotanicaltraditionalContextpreparationsresearchevidencesafetyproductEvaluationrelationshipssources

Created the Ginger Herb Profile v1 with canonical Zingiber officinale Roscoe identity, rhizome as canonical herbal material, preparation-aware human evidence across pregnancy nausea/vomiting, menstrual pain, motion sickness, osteoarthritis/pain and gastrointestinal outcomes, cautious safety framing, product-evaluation criteria and auditable review metadata.

This profile is provided for educational purposes only and is not medical advice. Traditional context and research summaries are distinguished from claims, and nothing here is a treatment recommendation. Always consult a qualified healthcare professional before using any herb, especially if you are pregnant, nursing, take medication, or have a medical condition.